Identification of intracellular cavin target proteins reveals cavin-PP1alpha interactions regulate apoptosis.
Kerrie-Ann McMahonYeping WuYann GambinEmma SiereckiVikas A TilluThomas E HallNick MartelSatomi OkanoShayli Varasteh MoradiJayde E RuelckeCharles FergusonAlpha S YapKirill AlexandrovMichelle M HillRobert G PartonPublished in: Nature communications (2019)
Caveolae are specialized domains of the plasma membrane. Formation of these invaginations is dependent on the expression of Caveolin-1 or -3 and proteins of the cavin family. In response to stress, caveolae disassemble and cavins are released from caveolae, allowing cavins to potentially interact with intracellular targets. Here, we describe the intracellular (non-plasma membrane) cavin interactome using biotin affinity proteomics and mass spectrometry. We validate 47 potential cavin-interactor proteins using a cell-free expression system and protein-protein binding assays. These data, together with pathway analyses, reveal unknown roles for cavin proteins in metabolism and stress signaling. We validated the interaction between one candidate interactor protein, protein phosphatase 1 alpha (PP1α), and Cavin-1 and -3 and show that UV treatment causes release of Cavin3 from caveolae allowing interaction with, and inhibition of, PP1α. This interaction increases H2AX phosphorylation to stimulate apoptosis, identifying a pro-apoptotic signaling pathway from surface caveolae to the nucleus.
Keyphrases
- protein protein
- mass spectrometry
- small molecule
- cell free
- signaling pathway
- cell death
- poor prognosis
- oxidative stress
- endoplasmic reticulum stress
- cell cycle arrest
- reactive oxygen species
- binding protein
- high throughput
- anti inflammatory
- risk assessment
- dna methylation
- single cell
- pi k akt
- epithelial mesenchymal transition
- electronic health record
- transcription factor
- genome wide
- heat stress
- data analysis
- circulating tumor
- deep learning
- climate change
- smoking cessation
- dna binding
- gas chromatography
- ms ms
- replacement therapy
- solid phase extraction